Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Acts To Block Fatal Fake Of Diabetes Drug Brand

This article was originally published in PharmAsia News

Executive Summary

Chinese food and drug authorities have arrested four people suspected of selling lethal fake copies of Tang Zhi Ning Jiao Nang, a drug for treating diabetes. The State FDA began a national search for other evidence of the drugs after two patients died in an autonomous province. The suspect drugs were found to contain glibenclamide, masked as a drug once made by Guangxi Pingnan Pharmaceutical. The SFDA ordered medical institutions to stop using the brand for diabetes until they could be checked and to record cases where the brand was used and submit samples to local inspection agencies. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC070841

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel